Intermediate
Informed consent (in neurotech)
Also known as: Consent, Post-trial access
Making sure people understand the risks, benefits and long-term implications before agreeing to a neural device or sharing brain data.
BCI trials raise special consent issues: what happens to the implant when the trial or company ends (post-trial access), who owns the data, and how to get consent from people who can communicate only in very limited ways. These questions are a growing focus for ethicists and regulators.
Last updated Sep 30, 2026. Educational content, not medical advice.